HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of canine pyoderma with co-amoxyclav: a comparison of two dose rates.

Abstract
The efficacy of oral co-amoxyclav, administered twice daily for up to 12 weeks either at the manufacturer's dose rate of 12.5 mg/kg or at 25.0 mg/kg, in curing the lesions of canine folliculitis, furunculosis and cellulitis was compared in a blind study. A total of 97 dogs entered the trial and 67 completed it. There was no significant difference in the rate of cure or the duration of therapy. The lesions of folliculitis were cured in 91.5 per cent of cases, in a mean period of 25.3 days. Furunculosis and cellulitis were cured respectively in 87.5 per cent and 60.0 per cent of the dogs, in mean periods of 37.6 and 44.7 days. The standard dose rate was very effective in folliculitis and furunculosis and there was no benefit in doubling the dose. Too few cases of cellulitis were treated to provide a reliable dose comparison.
AuthorsD H Lloyd, D N Carlotti, H J Koch, A H Van den Broek
JournalThe Veterinary record (Vet Rec) Vol. 141 Issue 17 Pg. 439-41 (Oct 25 1997) ISSN: 0042-4900 [Print] England
PMID9369001 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Anti-Bacterial Agents
  • Penicillins
  • Clavulanic Acid
  • Amoxicillin
Topics
  • Amoxicillin (administration & dosage, pharmacology)
  • Animals
  • Anti-Bacterial Agents (administration & dosage, pharmacology)
  • Bacterial Infections (drug therapy, veterinary)
  • Cellulitis (drug therapy, veterinary)
  • Clavulanic Acid (administration & dosage, pharmacology)
  • Dog Diseases (drug therapy)
  • Dogs
  • Dose-Response Relationship, Drug
  • Drug Therapy, Combination (administration & dosage, pharmacology)
  • Furunculosis (drug therapy, veterinary)
  • Penicillins (administration & dosage, pharmacology)
  • Pyoderma (drug therapy, veterinary)
  • Random Allocation
  • Single-Blind Method
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: